The summary below is from the full report titled “Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C. A Randomized Study of Treatment Duration and Ribavirin Dose.” It is in the 2 March 2004 issue of Annals of Internal Medicine (volume 140, pages 346-355). The authors are S.J. Hadziyannis, H. Sette Jr., T.R. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer Jr., D. Bernstein, M. Rizzetto, S. Zeuzem, P.J. Pockros, A. Lin, and A.M. Ackrill, for the PEGASYS International Study Group.
Duration and Dose of Antiviral Treatment for Chronic Hepatitis C. Ann Intern Med. 2004;140:I–67. doi: https://doi.org/10.7326/0003-4819-140-5-200403020-00004
Download citation file:
Published: Ann Intern Med. 2004;140(5):I-67.
Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Viral Hepatitis.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use